The term prfA primarily refers to two distinct biological entities:
Peptide chain release factor 1 (RF1) in Escherichia coli, which recognizes UAG/UAA stop codons during translation termination .
PrfA transcriptional activator in Listeria monocytogenes, a virulence regulator unrelated to translation termination .
For Acidovorax ebreus, genomic sequencing of strain TPSY reveals a 3.8 Mbp genome encoding 3,479 proteins, but no annotated prfA homologs linked to translation termination or transcriptional regulation .
While no studies specifically address recombinant RF1/PrfA in A. ebreus, commercial platforms list recombinant proteins from this species, including:
| Protein Name | Uniprot ID | Function | Source |
|---|---|---|---|
| Probable rRNA maturation factor | B9MDC6 | RNA processing | Yeast/E. coli |
| Intracellular septation protein | B9MAB3 | Cell division | Mammalian cells |
These examples highlight the feasibility of producing A. ebreus proteins recombinantly, though none are RF1/PrfA homologs.
RF1/RF2 mechanisms are best characterized in E. coli:
Key findings:
Truncation of RF1’s N-terminal domain retains activity, unlike RF2 .
Frameshifting in RF2 occurs at ~50% efficiency to bypass in-frame UGA codons .
Strain TPSY is an anaerobic nitrate-dependent Fe(II) oxidizer with genomic adaptations for environmental resilience :
Respiratory Flexibility: Contains terminal oxidases for diverse electron acceptors (e.g., nitrate, Fe(III)) .
Horizontal Gene Transfer (HGT): Enriched transposases and type IV secretion systems in genomic islands .
Codon Usage Bias: Elevated ENC values in accessory genomic regions suggest recent HGT events .
Hypothetical production of A. ebreus RF1 would require:
Gene Identification: Mining TPSY’s genome for RF1/RF2 homologs.
Expression Optimization: Codon adaptation for hosts like E. coli or yeast.
Functional Validation: Stop codon recognition assays (e.g., in vitro translation systems).
Existing protocols for A. ebreus recombinant proteins (e.g., storage in Tris-glycerol buffers, >85% purity via SDS-PAGE ) could guide such efforts.
Homolog Identification: No RF1-like genes are annotated in A. ebreus TPSY . Potential low-sequence homology may necessitate advanced BLAST searches.
Functional Studies: If homologs exist, in vitro assays (e.g., ribosome binding, GTPase activation) would clarify their roles.
Biotechnological Applications: Engineered release factors could optimize recombinant protein yields in industrial strains.
KEGG: dia:Dtpsy_0780
STRING: 535289.Dtpsy_0780
Based on comparative genomics, A. ebreus prfA likely shares structural similarity with other bacterial peptide chain release factors. These proteins typically contain domains for stop codon recognition and peptidyl-tRNA hydrolysis. In other bacteria, RF1 and RF2 exhibit significant sequence homology, suggesting similar tertiary structures despite their different stop codon specificities . Detailed structural studies specifically on A. ebreus prfA would require X-ray crystallography or cryo-EM analysis to confirm these structural predictions.
The prfA gene in Acidovorax ebreus is part of its completed genome sequence. While the search results don't provide specific details about the prfA gene locus, the complete genome of A. ebreus strain TPSY has been sequenced, revealing an organism optimized for survival in complex environmental systems . Genomic analysis using platforms like Anvi'o 6.2 would allow identification and characterization of the prfA gene within the context of the entire A. ebreus genome .
For recombinant expression of A. ebreus prfA, E. coli is likely the preferred heterologous expression system, as demonstrated with other A. ebreus proteins. For example, the recombinant UPF0060 membrane protein from A. ebreus was successfully expressed in E. coli with an N-terminal His-tag . When expressing A. ebreus prfA, researchers should consider:
| Expression Parameter | Recommended Condition | Rationale |
|---|---|---|
| Host strain | E. coli BL21(DE3) | Reduced protease activity |
| Expression vector | pET-series with T7 promoter | Strong, inducible expression |
| Induction conditions | 0.5-1.0 mM IPTG, 25-30°C | Balance between yield and solubility |
| Tags | N-terminal His-tag | Facilitates purification with minimal impact on function |
| Growth media | LB or TB supplemented with glucose | Enhanced protein yield |
Based on protocols for similar bacterial proteins, a multi-step purification strategy is recommended:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged protein
Intermediate purification: Ion exchange chromatography to separate based on charge properties
Polishing step: Size exclusion chromatography to achieve high purity
For buffer optimization, consider using Tris/PBS-based buffer with 6% trehalose at pH 8.0, similar to conditions used for other A. ebreus proteins . Adding glycerol (5-50% final concentration) helps maintain stability during storage, with 50% being commonly used for long-term storage at -20°C/-80°C .
To maintain stability and functionality of purified recombinant A. ebreus prfA:
Store at -20°C/-80°C upon receipt
Perform aliquoting for multiple use to avoid repeated freeze-thaw cycles
Consider adding glycerol to a final concentration of 50%
For working stocks, store aliquots at 4°C for up to one week
Avoid repeated freezing and thawing as this can significantly reduce protein activity
To assess the functional activity of recombinant A. ebreus prfA, researchers can employ several in vitro assays:
Peptidyl-tRNA hydrolysis assay: Measure the release of radiolabeled or fluorescently labeled peptides from purified peptidyl-tRNA substrates
Translation termination efficiency assay: Utilize reconstituted in vitro translation systems with reporter constructs containing specific stop codons
Ribosome binding assay: Assess direct binding between purified A. ebreus prfA and bacterial ribosomes using techniques such as surface plasmon resonance or filter binding assays
These assays would need to be adapted from protocols established for other bacterial release factors, as specific A. ebreus prfA activity assays are not described in the search results.
Based on knowledge of other bacterial release factors, A. ebreus prfA likely recognizes UAG and UAA stop codons, similar to RF1 in E. coli . To experimentally determine codon specificity, researchers could:
Perform in vitro translation termination assays using mRNAs with different stop codons
Create genetic complementation studies in RF-deficient bacterial strains
Conduct mutational analysis of the codon recognition domain
Use bioinformatic approaches to compare the recognition domains with well-characterized release factors
While specific information about A. ebreus prfA regulation is not provided in the search results, insights can be drawn from studies on peptide chain release factors in other bacteria. In E. coli, RF2 (a related release factor) is regulated by a unique autogenous mechanism involving an in-frame UGA stop codon that requires a +1 frameshift for expression . This results in tight regulation of RF2 levels, which are maintained at low concentrations relative to other translation factors .
Similar regulatory mechanisms might exist for A. ebreus prfA, though experimental verification would be necessary. Techniques to study prfA regulation could include:
Reporter gene fusions to monitor expression levels
Quantitative RT-PCR to measure transcript abundance under different conditions
Proteomic analysis to determine protein levels in various growth phases
Acidovorax ebreus is an anaerobic iron-oxidizing bacterium, optimized for survival in complex environmental systems . Environmental factors that might influence prfA function include:
Oxygen levels: As an anaerobic organism, A. ebreus likely has adaptations in translation termination efficiency under varying oxygen concentrations
Iron availability: Given its iron-oxidizing capabilities, iron concentration may affect global gene expression, potentially including prfA
Nitrogen sources: A. ebreus is nitrate-dependent , suggesting potential regulatory links between nitrogen metabolism and translation efficiency
Researchers could investigate these environmental influences through comparative proteomic and transcriptomic analyses under varying growth conditions.
For comprehensive structural characterization of A. ebreus prfA, researchers should consider:
X-ray crystallography: To obtain high-resolution structures, potentially in complex with ribosomal components
Cryo-electron microscopy: Particularly valuable for visualizing prfA in the context of the ribosomal termination complex
Hydrogen/deuterium exchange mass spectrometry: To identify dynamic regions and conformational changes upon substrate binding
Small-angle X-ray scattering (SAXS): For solution-state structural information
Nuclear magnetic resonance (NMR): For studying dynamics and smaller domains of the protein
These approaches could reveal insights similar to those found for other bacterial release factors or regulatory proteins like Listeria PrfA, where crystal structure analysis has been crucial for understanding function .
To study the protein-protein interaction network of A. ebreus prfA, researchers could employ:
Pull-down assays: Using tagged recombinant prfA to identify interacting partners
Yeast two-hybrid or bacterial two-hybrid screens: For systematic identification of protein partners
Biolayer interferometry or surface plasmon resonance: To measure binding kinetics and affinities
Crosslinking coupled with mass spectrometry: To capture transient interactions during translation termination
Fluorescence resonance energy transfer (FRET): For studying interactions in solution or in vivo
These methods could help map the functional interaction network of prfA within the context of the A. ebreus translation machinery.
Researchers can use site-directed mutagenesis to systematically analyze structure-function relationships in A. ebreus prfA:
Target conserved residues identified through sequence alignment with well-characterized release factors
Focus on domains responsible for:
Stop codon recognition
Peptidyl-tRNA hydrolysis
Ribosome binding
Create alanine scanning libraries across functional domains
Design mutations based on predictive structural models
Mutants can be assessed using the functional assays described in section 3.1, allowing correlation of structural features with specific functions.
Key insights that may be applicable to A. ebreus prfA research include:
The frameshifting mechanism observed in E. coli RF2 expression occurs at a remarkably high rate of 50%, suggesting sophisticated translational regulation
Release factors are typically found at low concentrations relative to other translation factors, indicating tight regulation
The significant sequence homology between RF1 and RF2 in E. coli suggests a common evolutionary origin despite different specificities
The binding promiscuity observed with regulatory proteins like Listeria PrfA might provide insights into potential moonlighting functions
These concepts could guide experimental design for A. ebreus prfA characterization, especially regarding regulatory mechanisms and evolutionary relationships.
To explore the evolutionary context of A. ebreus prfA, researchers should consider:
Conducting phylogenetic analysis across diverse bacterial species
Comparing sequence conservation patterns in functional domains
Analyzing selection pressures on different regions of the protein
Investigating potential horizontal gene transfer events
Tools like Anvi'o 6.2 used for Acidovorax pan-genome analysis could be applied to study prfA evolution across strains . This approach could reveal how prfA contributed to A. ebreus adaptation to its ecological niche as an anaerobic iron-oxidizer.
Pan-genomic analysis, as applied to Acidovorax species in previous studies , could reveal:
Conservation levels of prfA across different Acidovorax strains
Presence of paralogous genes or alternative release factors
Strain-specific variations that might correlate with ecological adaptations
Co-evolution patterns with interacting translation factors